Form 8-K - Current report:
SEC Accession No. 0001193125-24-163081
Filing Date
2024-06-18
Accepted
2024-06-18 08:36:09
Documents
61
Period of Report
2024-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d804506d8k.htm   iXBRL 8-K 30817
2 EX-99.1 d804506dex991.htm EX-99.1 11013
3 EX-99.2 d804506dex992.htm EX-99.2 58818
7 GRAPHIC g804506ex99_2p10g1.jpg GRAPHIC 275216
8 GRAPHIC g804506ex99_2p11g1.jpg GRAPHIC 258974
9 GRAPHIC g804506ex99_2p12g1.jpg GRAPHIC 255821
10 GRAPHIC g804506ex99_2p13g1.jpg GRAPHIC 474845
11 GRAPHIC g804506ex99_2p14g1.jpg GRAPHIC 207525
12 GRAPHIC g804506ex99_2p15g1.jpg GRAPHIC 246573
13 GRAPHIC g804506ex99_2p16g1.jpg GRAPHIC 248226
14 GRAPHIC g804506ex99_2p17g1.jpg GRAPHIC 249615
15 GRAPHIC g804506ex99_2p18g1.jpg GRAPHIC 230834
16 GRAPHIC g804506ex99_2p19g1.jpg GRAPHIC 229540
17 GRAPHIC g804506ex99_2p1g1.jpg GRAPHIC 267676
18 GRAPHIC g804506ex99_2p20g1.jpg GRAPHIC 306287
19 GRAPHIC g804506ex99_2p21g1.jpg GRAPHIC 232069
20 GRAPHIC g804506ex99_2p22g1.jpg GRAPHIC 404309
21 GRAPHIC g804506ex99_2p23g1.jpg GRAPHIC 352383
22 GRAPHIC g804506ex99_2p24g1.jpg GRAPHIC 288929
23 GRAPHIC g804506ex99_2p25g1.jpg GRAPHIC 251356
24 GRAPHIC g804506ex99_2p26g1.jpg GRAPHIC 203725
25 GRAPHIC g804506ex99_2p27g1.jpg GRAPHIC 226998
26 GRAPHIC g804506ex99_2p28g1.jpg GRAPHIC 259827
27 GRAPHIC g804506ex99_2p29g1.jpg GRAPHIC 276633
28 GRAPHIC g804506ex99_2p2g1.jpg GRAPHIC 490561
29 GRAPHIC g804506ex99_2p30g1.jpg GRAPHIC 264842
30 GRAPHIC g804506ex99_2p31g1.jpg GRAPHIC 309514
31 GRAPHIC g804506ex99_2p32g1.jpg GRAPHIC 62069
32 GRAPHIC g804506ex99_2p33g1.jpg GRAPHIC 291392
33 GRAPHIC g804506ex99_2p34g1.jpg GRAPHIC 300318
34 GRAPHIC g804506ex99_2p35g1.jpg GRAPHIC 381054
35 GRAPHIC g804506ex99_2p36g1.jpg GRAPHIC 266965
36 GRAPHIC g804506ex99_2p37g1.jpg GRAPHIC 328937
37 GRAPHIC g804506ex99_2p38g1.jpg GRAPHIC 309752
38 GRAPHIC g804506ex99_2p39g1.jpg GRAPHIC 244021
39 GRAPHIC g804506ex99_2p3g1.jpg GRAPHIC 376798
40 GRAPHIC g804506ex99_2p40g1.jpg GRAPHIC 359986
41 GRAPHIC g804506ex99_2p41g1.jpg GRAPHIC 262021
42 GRAPHIC g804506ex99_2p42g1.jpg GRAPHIC 252493
43 GRAPHIC g804506ex99_2p43g1.jpg GRAPHIC 263075
44 GRAPHIC g804506ex99_2p44g1.jpg GRAPHIC 304761
45 GRAPHIC g804506ex99_2p45g1.jpg GRAPHIC 328832
46 GRAPHIC g804506ex99_2p4g1.jpg GRAPHIC 269916
47 GRAPHIC g804506ex99_2p5g1.jpg GRAPHIC 258706
48 GRAPHIC g804506ex99_2p6g1.jpg GRAPHIC 215878
49 GRAPHIC g804506ex99_2p7g1.jpg GRAPHIC 390822
50 GRAPHIC g804506ex99_2p8g1.jpg GRAPHIC 271177
51 GRAPHIC g804506ex99_2p9g1.jpg GRAPHIC 394215
52 GRAPHIC g804506g0618084810522.jpg GRAPHIC 3003
  Complete submission text file 0001193125-24-163081.txt   18093257

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dawn-20240617.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dawn-20240617_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dawn-20240617_pre.xml EX-101.PRE 11265
64 EXTRACTED XBRL INSTANCE DOCUMENT d804506d8k_htm.xml XML 3654
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 241050282
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)